Sensitivity of experimental venous and arterial thrombosis and bleeding to ancrod-induced defibrinogenation

Thrombosis Research

Volumn 81, Issue 2, 1996, Pages 187-194

  Schumacher, William A ^a   Heran, Christopher L ^a   Steinbacher, Thomas E ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Ancrod; Arterial and venous thrombosis; Bleeding time; Fibrinogen; Rat

Indexed keywords

ANCROD; FIBRINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY THROMBOSIS; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VEIN THROMBOSIS;

EID: 0029917901     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00235-9     Document Type: Article

References (17)

1. MOSESSEN, M.W. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Sem. Hematol. 29, 177-188, 1992.
2. WILHELMSEN, L., SVÄRDSUDD, K., KORSAN-BENGTSEN, K., LARSSON, B., WELIN, L. and TIBBLIN, G. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 311, 501-505, 1984.
3. YARNELL, J.W.G., BAKER, I.A., SWEETNAM, P.M., BAINTON, D., O'BRIEN, J.R., WHITEHEAD, P.J. and ELWOOD, P.C. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation 83, 836-844, 1991.
4. SCHUMACHER, W.A., STEINBACHER, T.E., HERAN, C.L., SEILER, S.E., MICHEL, I. and OGLETREE, M.L. Comparison of thrombin active-site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding. J. Pharmacol. Exp. Ther. 267, 1237-1242, 1993.
5. SCHUMACHER, W.A., SEILER, S.E., ST. LAURENT, D.R. and BALASUB-RAMANIAN, N. Effect of a novel thrombin active-site inhibitor on arterial and venous thrombosis. Eur. J. Pharmacol. 259, 165-171, 1994.
6. SEIFRIED, E., OETHINGER, M. TANSWELL, P., HOEGEE-DE NOBEL, E. and NIEUWENHUIZEN, W. Influence of acute myocardial infarction and rtPA therapy on circulating fibrinogen. Thromb. Haemostas. 63, 321-327, 1993.
7. HANDAGAMA, P.J., SHUMAN, M.A. and BAINTON, D.F. In vivo defibrination results in markedly decreased amounts of fibrinogen in rat megakaryocytes and platelets. Am. J. Pathol. 137, 1393-1396, 1990.
8. POLLACK, V.E., GLAS-GREENWALT, P., OLINGER, C.P., WADHWA, N.K., and MYRE, S.A. Ancrod causes rapid thrombolysis in patients with acute stroke. Am. J. Med. Sci. 299: 319-325, 1990.
9. COOLEY, B.C., FOWLER, J.D. and GOULD, J.S. Physiologic alteration of fibrinogen levels: influence upon patency of microvenous anastomoses. Microsurgery 13, 299-303, 1992
10. OLSSON, P., LJUNGQVIST, A., and GÖRANSSON, L. Vein graft surgery in defibrase-defibrinogenated dogs. Thromb. Res. 3, 161-172, 1973.
11. APPRILL, P.G., ASHTON, J., GUERRERO, J., GLAS-GREENWALT, P., BUJA, L.M. and WILLERSON, J.T. Ancrod decreases the frequency of cyclic flow variations and causes thrombolysis following acute coronary thrombosis. Am. Heart J. 113, 898-906, 1987.
12. CHANG, M-C. and HUANG, T-F. In vivo effect of a thrombin-like enzyme on platelet plug formation induced in mesenteric microvessels of mice. Thromb. Res. 73, 31-38, 1994.
13. CERECK, B., LEW, A.S., HOD, H., YANO, J., REDDY, N.K. and GANZ, W. Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin. Circulation 74: 583-587, 1986.
14. LATALLO, Z.S. Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes - a multicenter trial. Thromb. Haemostas. 50, 604-609, 1983.
15. BELCH, J.J., MEEK, D.R., LOWE, G.D., CAMPBELL, A.F., YOUNG, A.B., FORBES, C.D. and PRENTICA, C.R. Subcutaneous ancrod in prevention of deep vein thrombosis after hip replacement surgery. Thromb. Res. 25, 23-31, 1982.
16. COLE, C.W., BORMANIS, J., LUNA, G.K., HAJJAR, G., BARBER, G.G., HARRIS, K.A. and BRIEN, W.F. Ancrod versus heparin for anticoagulation during vascular surgical procedures. J. Vasc. Surg. 17, 288-292, 1988.
17. DEMERS, C., GINSBERG, J.S., BRILL-EDWARDS, P., PANJU, A., WARKENTIN, T.E., ANDERSON, D.R., TURNER, C. and KELTON, J.G. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood 78, 2194-2197, 1991.